Metraipolis › archive › dc_6543c2f8b2bc
Survival and Surrogate Biomarkers in Interventional Oncology Trials: Pitfalls, Challenges, and Future Directions — Europe PMC PMID:41545771
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41545771
- DOI
- 10.1007/s00270-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T18:40:43.324Z
- SHA-256 of the archived text
eabbd147139f67dae9372c04719a792bd885f0c0c76b3db0547294c0f8caeb22- Stable URL of this page
https://metraipolis.com/documento/dc_6543c2f8b2bc
How to cite
Survival and Surrogate Biomarkers in Interventional Oncology Trials: Pitfalls, Challenges, and Future Directions — Europe PMC PMID:41545771 — Europe PMC (en), https://europepmc.org/article/MED/41545771 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6543c2f8b2bc (Metraipolis archive dc_6543c2f8b2bc, sha256 eabbd147139f67dae9372c04719a792bd885f0c0c76b3db0547294c0f8caeb22)
BibTeX
@misc{dc6543c2f8b2bc,
title = {Survival and Surrogate Biomarkers in Interventional Oncology Trials: Pitfalls, Challenges, and Future Directions — Europe PMC PMID:41545771},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41545771},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6543c2f8b2bc; sha256 eabbd147139f67dae9372c04719a792bd885f0c0c76b3db0547294c0f8caeb22},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41545771. Agents can read the archived copy with the MCP tool read_document.